Identification | Back Directory | [Name]
Pramipexole Dimer Impurity (Mixture of Diastereomers) | [CAS]
1147937-31-2 | [Synonyms]
N6-Propyl pramipexole (S)-Propyl Pramipexole 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6,N6-dipropyl-, (6S)- PRAMIPEXOLE IMPURITY F/(S)-N6,N6-DIPROPYL-4,5,6,7-TETRAHYDROBENZO[D]THIAZOLE-2,6-DIAMINE | [Molecular Formula]
C13H23N3S | [MOL File]
1147937-31-2.mol | [Molecular Weight]
253.41 |
Chemical Properties | Back Directory | [Melting point ]
>96°C (dec.) | [Boiling point ]
400.9±45.0 °C(Predicted) | [density ]
1.10±0.1 g/cm3(Predicted) | [storage temp. ]
-20°C Freezer | [solubility ]
Chloroform (Slightly), Methanol (Slightly, Sonicated) | [form ]
Solid | [pka]
8.83±0.20(Predicted) | [color ]
Pale Yellow to Light Beige |
Hazard Information | Back Directory | [Uses]
(S)- Propyl Pramipexole is (S)-Pramipexole (P700750) analogue. (S)-Pramipexole (P700750) is a dopamine-D2-receptor agonist. Antiparkinsonian. Pramipexole (Mirapex, Mirapexin, Sifrol) is a non-ergoline dopamine agonist indicated for treating early-stage Parkinson''s disease (PD) and restless legs syndrome (RLS).[1] It is also sometimes used off-label as a treatment for cluster headache and to counteract the problems with sexual dysfunction experienced by some users of the selective serotonin reuptake inhibitor (SSRI) antidepressants. |
|
|